Integrative Multi-Omics Analysis Using Machine Learning for Biomarker Discovery in Ankylosing Spondylitis
International Journal of Innovations in Science and Technology · 15.10.2026 · 8 (8) · 3521
DOI: 10.33411/ijist/2093 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovations in Science and Technology, online erschienen am 15.10.2026. Verfasst von Izaz Ullah und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ankylosing Spondylitis (AS) is a chronic immune-mediated inflammatory disease in which genetic susceptibility, antigen-processing mechanisms, cytokine signaling, and cellular immune responses interact with environmental and tissue-specific factors. Blood transcriptomic studies have identified candidate molecular signatures of AS, and machine-learning approaches can reduce high-dimensional expression data to compact predictive feature sets. However, small cohorts, biological heterogeneity, platform differences, and repeated model redevelopment during external testing can lead to optimistic estimates of biomarker performance.
Objective
We evaluated an evidence-controlled transcriptomic and machine-learning framework for AS biomarker discovery centered on a nine-gene signature identified during discovery and subsequently locked before independent external evaluation. Particular attention was given to GNLY and GZMK as cytotoxic/effector-associated candidate genes.
Methods
The principal transcriptomic discovery resource was GSE73754, containing 72 samples (52 AS and 20 healthy controls; 37 male and 35 female). Nine genes—CD160, GZMK, GNLY, NKG7, GZMA, KLRB1, KLRD1, IL2RB, and ITGA2B—met the prespecified statistical selection criterion and were subsequently frozen. The model-development resource, GSE18781, contained 43 samples (18 AS and 25 controls). The reproducible classifier pipeline was mean imputation, StandardScaler, and logistic regression (C=0.1; liblinear; max_iter=5000; random_state=42), evaluated with 20 repeated cross-validation iterations, 2,000 bootstrap resamples, and 2,000 permutation tests. The archived principal model-development analysis reported mean ROC-AUC 0.689 (SD 0.028; archived 95% CI 0.633–0.741). GSE221786 was independently audited at the raw-matrix and biological sample-identity levels and contained 28 samples (20 AS and 8 controls), with all nine genes present and no missing expression cells. The original serialized classifier binary was not recovered; therefore, GSE221786 was evaluated at the frozen-signature gene-expression level without model refitting, gene reselection, threshold optimization, hyperparameter tuning, or recalibration.
Results
The archived principal model-development analysis yielded accuracy 0.691, precision 0.667, recall 0.529, F1 0.589, and MCC 0.354; the permutation test gave P=0.052, which was not conventionally significant at α=0.05. In GSE221786, no gene satisfied the complete predefined external-replication criterion. GNLY showed the strongest individual external discrimination (AUC=0.704–0.706 depending on the archived external analysis) and a 5.35-fold descriptive difference, but its direction was discordant with the discovery pattern and its external P value was not significant. GZMK and IL2RB showed directional concordance but weak discrimination. Positional integration of IGAS summary statistics identified KLRB1 as the strongest genetically supported member of the signature (Fisher combined P=0.0223; BH-FDR=0.0670).
Conclusion
The findings support an evidence-controlled integrative multi-omics framework in which transcriptomic, machine-learning, functional, and genetic/HLA evidence are evaluated separately and then interpreted jointly. GNLY and GZMK remain priority transcriptomic candidates requiring further validation, while KLRB1 provides the strongest positional genetic support within the signature. None of the genes should currently be considered a clinically validated biomarker or causal disease mediator.
Zitieren
APA
Ullah, I., Jan, S., Haq, I. U., Talha, M., & Khan, I. A. (2026). Integrative Multi-Omics Analysis Using Machine Learning for Biomarker Discovery in Ankylosing Spondylitis. International Journal of Innovations in Science and Technology, 8(8), 3521. https://doi.org/10.33411/ijist/2093
Vancouver
Ullah I, Jan S, Haq IU, Talha M, Khan IA. Integrative Multi-Omics Analysis Using Machine Learning for Biomarker Discovery in Ankylosing Spondylitis. International Journal of Innovations in Science and Technology. 2026;8(8):3521. doi:10.33411/ijist/2093
BibTeX
@article{Ullah2026,
author = {Ullah, Izaz and Jan, Sakin and Haq, Inzamam Ul and Talha, Muhammad and Khan, Israr Ahmad},
title = {Integrative Multi-Omics Analysis Using Machine Learning for Biomarker Discovery in Ankylosing Spondylitis},
journal = {International Journal of Innovations in Science and Technology},
year = {2026},
volume = {8},
number = {8},
pages = {3521},
doi = {10.33411/ijist/2093}
}
EUVIMED